![](https://www.inotrem.com/wp-content/uploads/2020/01/INOTREM-NS.png)
Inotrem announce the appointment of Luke Beshar as Chairman of Board of Directors
Paris (France), May 31. 2022. Inotrem, an advanced clinical stage biotech company developing TREM- 1 targeting immunotherapies for acute and chronic inflammatory syndromes, announced today